| A Study in Healthy Men to Test Whether Four Capsules of 25 mg Nintedanib Are Taken up in the Body in the Same Way as One 100 mg Capsule (NCT04938453) | Boehringer Ingelheim | 2021-07-14 |
| Beamion LUNG-1: A Study to Test Different Doses of Zongertinib in People With Different Types of Advanced Cancer (Solid Tumours With Changes in the HER2 Gene) (NCT04886804) | Boehringer Ingelheim | 2021-07-02 |
| A Study in Healthy Men to Find the Best Formulation of BI 685509 and to Test How it is Taken up in the Body (NCT04926246) | Boehringer Ingelheim | 2021-07-01 |
| A Study in Healthy Men and Women to Test Whether BI 1358894 Influences the Amount of Bupropion in the Blood (NCT04899674) | Boehringer Ingelheim | 2021-06-30 |
| A Study in Chinese Patients to Compare How Tenecteplase and Alteplase Given After a Stroke Improve Recovering of Physical Activity (NCT04915729) | Boehringer Ingelheim | 2021-06-22 |
| A Study to Test Whether BI 767551 Can Prevent COVID-19 in People Who Have Been Exposed to SARS-CoV-2 (NCT04894474) | Boehringer Ingelheim | 2021-06-17 |
| A Study in Men With Overweight to Test How Well Different Doses of BI 1820237 Are Tolerated When Given as an Injection Alone or in Combination With Liraglutide (NCT04903509) | Boehringer Ingelheim | 2021-06-08 |
| This Study Combines Data From 3 Other Studies Testing Empagliflozin in Patients With Diabetes or With Chronic Heart Failure. The Study Looks at the Numbers of Patients Who Had Lower Limb Amputations (NCT04937816) | Boehringer Ingelheim | 2021-06-01 |
| INREAL - Nintedanib for Changes in Dyspnea and Cough in Patients Suffering From Chronic Fibrosing Interstitial Lung Disease (ILD) With a Progressive Phenotype in Everyday Clinical Practice: a Real-world Evaluation (NCT04702893) | Boehringer Ingelheim | 2021-05-28 |
| A Study in Healthy Men to Test How Well Different Doses of BI 1819479 Are Tolerated and Taken up by the Body With or Without Food (NCT04801693) | Boehringer Ingelheim | 2021-05-26 |
| A Study in Healthy Men to Test How BI 1595043 is Taken up in the Body When Given With or Without Food (NCT04789291) | Boehringer Ingelheim | 2021-05-18 |
| A Study Evaluating Different Doses of BI 765049 When Given Alone and When Given With Ezabenlimab to Patients With Advanced Solid Tumors Expressing the Protein B7-H6 on the Cell Surface (NCT04752215) | Boehringer Ingelheim | 2021-05-18 |
| A Trial in Healthy Men and Women to Find Out How Well Different Doses of BI 1291583 Are Tolerated (NCT04866160) | Boehringer Ingelheim | 2021-05-17 |
| Exacerbation Risk in Asthma (NCT05501639) | Boehringer Ingelheim | 2021-05-14 |
| A Study to Test the Effect of Different Doses of Avenciguat (BI 685509) on Kidney Function in People With Chronic Kidney Disease (NCT04736628) | Boehringer Ingelheim | 2021-04-27 |
| A Study to Test Safety and Efficacy of Survodutide (BI456906) in Adults With Non-alcoholic Steatohepatitis (NASH) and Fibrosis (F1-F3) (NCT04771273) | Boehringer Ingelheim | 2021-04-27 |
| A Study to Test the Effect of Different Doses of BI 685509 on Kidney Function in People With Diabetic Kidney Disease (NCT04750577) | Boehringer Ingelheim | 2021-04-27 |
| A Study to Test BI 767551 in People With Mild to Moderate Symptoms of COVID-19 (NCT04822701) | Boehringer Ingelheim | 2021-04-21 |
| A Study to Find a Safe and Effective Dose of BI 1701963 Alone and in Combination With BI 3011441 in Patients With Advanced Cancer and a Certain Mutation (Kirsten Rat Sarcoma Viral Oncogene Homologue [KRAS]) (NCT04835714) | Boehringer Ingelheim | 2021-04-20 |
| Proof of Concept Study Assessing Technology-Assisted Respiratory Adherence Prototype Version 3 in Individuals With COPD (NCT04795323) | Boehringer Ingelheim | 2021-04-08 |
| A Study to Test Whether Spesolimab Helps People With a Skin Disease Called Hidradenitis Suppurativa (NCT04762277) | Boehringer Ingelheim | 2021-04-06 |
| A Study to Test How Healthy Men Tolerate Different Doses of BI 1595043 (NCT04789304) | Boehringer Ingelheim | 2021-04-01 |
| Morbid Rates After Spiriva Chronic Obstructive Pulmonary Disease (COPD) Protocol Change (NCT06053541) | Boehringer Ingelheim | 2021-04-01 |
| A Study in Healthy People to Compare 3 Different Formulations of Apremilast Tablets Taken With or Without Food (NCT04811573) | Boehringer Ingelheim | 2021-03-31 |
| A Study in Healthy Men to Find Out How BI 1015550 is Taken up and Handled by the Body (NCT04771286) | Boehringer Ingelheim | 2021-03-25 |
| A Study to Test Different Doses of BI 3011441 in Japanese People With Different Types of Advanced Cancer (NRAS/KRAS Mutation Positive) (NCT04742556) | Boehringer Ingelheim | 2021-03-15 |
| A Study in Patients With Non-cystic Fibrosis Bronchiectasis to Test How Well Different Doses of BI 1323495 Are Tolerated and How BI 1323495 Affects Biomarkers of Inflammation (NCT04656275) | Boehringer Ingelheim | 2021-03-04 |
| A Study Using US Medical and Pharmacy Claim Records to Compare the Resource Use, Cost, and Outcomes of People With COPD Who Take Either Tiotropium + Olodaterol or Fluticasone + Umeclidinium + Vilanterol (NCT05127304) | Boehringer Ingelheim | 2021-02-26 |
| TARA Working Prototype [Version 2]: Feasibility Study (NCT04320524) | Boehringer Ingelheim | 2021-02-17 |
| Quality of Life in Chronic Obstructive Pulmonary Disease (COPD) Patients After Switching to Tiotropium Plus Olodaterol Fixed Dose Combination in Greece (NCT04672941) | Boehringer Ingelheim | 2021-02-16 |
| A Study in Healthy Men to Test How Itraconazole Influences the Amount of BI 706321 in the Blood (NCT04714073) | Boehringer Ingelheim | 2021-02-11 |
| A Study in Healthy Japanese Men to Test How Well Different Doses of BI 764198 Are Tolerated (NCT04665700) | Boehringer Ingelheim | 2021-02-06 |
| A Study in Healthy Men to Test How Itraconazole Influences the Amount of BI 474121 in the Blood (NCT04716894) | Boehringer Ingelheim | 2021-02-01 |
| NICEFIT-ON: A Study Under Routine Clinical Practice in Taiwan to Observe the Long-term Outcome of People With Certain Types of Lung Disease (PF-ILD, SSc-ILD, IPF) Who Start Treatment With Nintedanib (NCT04614441) | Boehringer Ingelheim | 2021-01-21 |
| A Study in Healthy Men to Test if Different Formulations of BI 764198 With or Without Food Influence the Amount of BI 764198 in the Blood (NCT04656288) | Boehringer Ingelheim | 2021-01-15 |
| A Study in Healthy Men to Test How the Body Takes up and Tolerates Different Doses of BI 765080 (NCT04666922) | Boehringer Ingelheim | 2021-01-14 |
| Safety and Effectiveness of Nintedanib in Korean Patients (NCT04525547) | Boehringer Ingelheim | 2021-01-13 |
| A Study in Healthy Men to Test How Different Doses of BI 474121 Are Taken up and How They Influence the Amount of a Molecular Messenger (cGMP) in the Spinal Fluid (NCT04672954) | Boehringer Ingelheim | 2021-01-07 |
| A Study in Healthy People to Test Whether BI 730357 Influences the Amount of Caffeine, Warfarin, Omeprazole, and Midazolam in the Blood (NCT04679948) | Boehringer Ingelheim | 2020-12-21 |
| A Study to Test Whether Different Doses of Alteplase Help People With Severe Breathing Problems Because of COVID-19 (NCT04640194) | Boehringer Ingelheim | 2020-12-16 |
| A Study in Healthy Men to Test Whether BI 409306, BI 425809 or Lamotrigine Can Reverse the Memory Problems Caused by Ketamine (NCT04602221) | Boehringer Ingelheim | 2020-12-01 |
| A Study to Test Different Doses of BI 1701963 in Combination With Irinotecan in People With Advanced Bowel Cancer With Kirsten Rat Sarcoma Viral Oncogene Homologue (KRAS) Mutation (NCT04627142) | Boehringer Ingelheim | 2020-11-23 |
| A Study to Test the Effect of Different Doses of BI 1358894 and Quetiapine in People With Depression (NCT04521478) | Boehringer Ingelheim | 2020-11-20 |
| A Study in Healthy Japanese Men to Test How Different Doses of BI 1323495 Are Tolerated and How Itraconazole Influences the Amount of BI 1323495 in the Blood (NCT04619251) | Boehringer Ingelheim | 2020-11-13 |
| ACTION ON COVID-19: A Study to Test Whether BI 764198 Helps Lung Health of People Hospitalised With COVID-19 (NCT04604184) | Boehringer Ingelheim | 2020-11-03 |
| COVID-19 Tests: Nasopharyngeal Swab vs Saliva Collected With Salivette® Cortisol for Viral RNA Sampling for RT-qPCR (NCT04599959) | Boehringer Ingelheim | 2020-10-26 |
| A Study in Healthy People to Test Whether BI 730357 Affects How 4 Other Medicines (Rosuvastatin, Digoxin, Metformin, and Furosemide) Are Taken up in the Body (NCT04590937) | Boehringer Ingelheim | 2020-10-20 |
| A Study in Healthy Men to Test How BI 1358894 is Taken up and Handled by the Body (NCT04567316) | Boehringer Ingelheim | 2020-10-19 |
| Real-World Effectiveness of Afatinib (Gilotrif) Following Immunotherapy in the Treatment of Metastatic, Squamous Cell Carcinoma of the Lung: A Multi-Site Retrospective Chart Review Study in the U.S. (NCT04750824) | Boehringer Ingelheim | 2020-10-15 |
| A Study in Healthy Men and Women Who Are Either Between 18 - 45 Years or Between 65 - 80 Years to Test How Different Doses of BI 474121 Are Tolerated (NCT04537897) | Boehringer Ingelheim | 2020-10-06 |
| A Study to Test How Well Empagliflozin Works in Japanese People With Type 2 Diabetes Who Are Older Than 65 Years (NCT04531462) | Boehringer Ingelheim | 2020-10-05 |
| Post-marketing Surveillance of Ofev Capsules in Chronic Fibrosing Interstitial Lung Diseases With a Progressive Phenotype in Japan (NCT04559581) | Boehringer Ingelheim | 2020-10-02 |
| Temporal Trends of Thrombolysis Treatment in Chinese Acute Ischemic Stroke (AIS) Patients From 2007-2017: Analysis of China National Stroke Registry (CNSR) I, II, and III; CTP-Draft Review Performed; (NCT04290494) | Boehringer Ingelheim | 2020-09-21 |
| A Study to Test BI 754091 Alone or in Combination With BI 836880 in People Who Have Advanced Anal Cancer (NCT04499352) | Boehringer Ingelheim | 2020-09-14 |
| A Study to Test Long-term Treatment With Spesolimab in People With Palmoplantar Pustulosis (PPP) Who Took Part in Previous Studies With Spesolimab (NCT04493424) | Boehringer Ingelheim | 2020-09-04 |
| ReAHEAD: A Study to Find Out Whether Education Improves Adherence to Dabigatran in People With Atrial Fibrillation Who Are Younger Than 75 Years (NCT04532528) | Boehringer Ingelheim | 2020-08-27 |
| A Study in Healthy Men to Test How Different Doses of BI 1595043 Are Tolerated (NCT04439838) | Boehringer Ingelheim | 2020-08-13 |
| A Study to Find the Best Dose of BI 1387446 Alone or in Combination With Ezabenlimab (BI 754091) in Patients With Different Types of Advanced or Metastatic Cancer (Solid Tumors) (NCT04147234) | Boehringer Ingelheim | 2020-08-03 |
| A Study to Test Different Doses of Obrixtamig in Patients With Small Cell Lung Cancer and Other Neuroendocrine Tumours That Are Positive for DLL3 (NCT04429087) | Boehringer Ingelheim | 2020-07-29 |
| A Study to Test How Taking BI 1015550 for 12 Weeks Affects Lung Function in People With Idiopathic Pulmonary Fibrosis (IPF) (NCT04419506) | Boehringer Ingelheim | 2020-07-28 |
| A Study in Healthy Men to Test How Well Different Doses of BI 1569912 Are Tolerated and How Food Influences the Amount of BI 1569912 in the Blood (NCT04445090) | Boehringer Ingelheim | 2020-07-21 |
| A Study in Healthy Men to Test How BI 1358894 is Taken up in the Body and How Food Influences the Amount of BI 1358894 in the Blood (NCT04426851) | Boehringer Ingelheim | 2020-07-13 |
| A Study to Test How Well Different Doses of BI 1356225 Are Tolerated by Men and Women With Obesity or Overweight (NCT04447261) | Boehringer Ingelheim | 2020-06-30 |
| A Study in Healthy Men to Compare 2 Different Formulations of Alteplase (NCT04419493) | Boehringer Ingelheim | 2020-06-23 |
| A Home-based Study Using Mobile Technology to Test Whether BI 1358894 is Effective in People With Depression (NCT04423757) | Boehringer Ingelheim | 2020-06-22 |
| HORNBILL: A Study to Test Different Doses of BI 764524 in Patients Who Have Had Laser Treatment for a Type of Diabetic Eye Disease Called Diabetic Retinopathy With Diabetic Macular Ischemia (NCT04424290) | Boehringer Ingelheim | 2020-06-12 |
| A Study to Test Whether BI 655130 (Spesolimab) Prevents Flare-ups in Patients With Generalized Pustular Psoriasis (NCT04399837) | Boehringer Ingelheim | 2020-06-04 |
| A Study to Test How Different Doses of BI 456906 Are Tolerated in Japanese Men With a Body Mass Index (BMI) Between 23 and 40 kg/m2 (NCT04384081) | Boehringer Ingelheim | 2020-06-01 |
| Post-marketing Surveillance on Long Term Use of Ofev Capsules in Systemic Scleroderma Associated Interstitial Lung Disease (SSc-ILD) in Japan (NCT04325217) | Boehringer Ingelheim | 2020-05-27 |
| A Trial in Healthy Chinese Volunteers to Test How Different Doses of BI 655130 Are Taken up in the Body (NCT04390568) | Boehringer Ingelheim | 2020-05-21 |
| The Study Observes Afatinib as First-line Treatment in Patients With Epidermal Growth Factor Receptor (EGFR) Mutation-positive Advanced Non-small Cell Lung Cancer (NCT04206787) | Boehringer Ingelheim | 2020-05-20 |
| A Study to Test the Effect of Empagliflozin in Patients Who Are in Hospital for Acute Heart Failure (NCT04157751) | Boehringer Ingelheim | 2020-05-18 |
| A Study to Test Long-term Treatment With Spesolimab in Patients With Fistulising Crohn's Disease Who Took Part in Previous Trials (NCT04362254) | Boehringer Ingelheim | 2020-05-15 |
| SITS-IVT in Patients >80 Years Study (NCT04260347) | Boehringer Ingelheim | 2020-05-14 |
| A Study in the United States Using Electronic Medical Records (EMR) to Assess Effectiveness of Afatinib (Gilotrif) Following Pembrolizumab and Chemotherapy in the Treatment of Metastatic Squamous Cell Carcinoma of the Lung (NCT04552535) | Boehringer Ingelheim | 2020-05-08 |
| A Study to Test Whether Different Doses of BI 456906 Are Effective in Treating Adults With Type 2 Diabetes. (NCT04153929) | Boehringer Ingelheim | 2020-04-30 |
| A Study to Test How Well Empagliflozin Works in Chinese Patients With Type 2 Diabetes Who Already Take Insulin (NCT04233801) | Boehringer Ingelheim | 2020-04-15 |
| A Study in South Korea Using Medical Records to Look at Different Treatments for Chronic Obstructive Airway Disease (COPD) (NCT04172701) | Boehringer Ingelheim | 2020-04-15 |
| Early Intervention Efficacy in COPD (NCT04249310) | Boehringer Ingelheim | 2020-03-27 |
| A Study to Find a Safe and Effective Dose of BI 905711 in Patients With Advanced Gastrointestinal Cancer (NCT04137289) | Boehringer Ingelheim | 2020-03-11 |
| Real-world Study Comparing the Adherence and Effectiveness of Linagliptin vs. Acarbose (NCT04180813) | Boehringer Ingelheim | 2020-03-04 |
| A Study in Healthy Men to Find the Best Formulation of BI 894416 and to Test How This is Taken up in the Body (NCT04232839) | Boehringer Ingelheim | 2020-02-25 |
| A Study in Healthy Men to Test How BI 1265162 is Taken up and Processed by the Body (NCT04267276) | Boehringer Ingelheim | 2020-02-18 |
| A Study to Test How Well Healthy Men and Women Tolerate Different Doses of BI 706321 (NCT04241458) | Boehringer Ingelheim | 2020-01-30 |
| A Study to Test the Combination of Tiotropium and Olodaterol Using the Respimat® Inhaler in People With Chronic Obstructive Pulmonary Disease (COPD) Who Have Different Abilities to Inhale (NCT04223843) | Boehringer Ingelheim | 2020-01-08 |
| A Study in Taiwan Based on Medical Records That Looks at the Occurrence of Flare-ups in Patients With Chronic Obstructive Pulmonary Disease (COPD) Who Started LABA/LAMA or LAMA Treatment (NCT04011475) | Boehringer Ingelheim | 2019-12-29 |
| A Trial to Find the Safe Dose for BI 905681 in Patients With Incurable Tumours or Tumours That Have Spread (NCT04147247) | Boehringer Ingelheim | 2019-12-23 |
| The Study Observes How Long Patients With Non-small Cell Lung Cancer (NSCLC) Benefit From Treatment With Epidermal Growth Factor Tyrosine Kinase Inhibitor (EGFR-TKI) When Given Either for Uncommon Mutations or for Common Mutations in the Sequence Afatinib Followed by Osimertinib (NCT04179890) | Boehringer Ingelheim | 2019-12-17 |
| A Study in People With Normal Kidney Function and People With Reduced Kidney Function to Test How BI 764198 is Processed in the Body (NCT04176536) | Boehringer Ingelheim | 2019-12-10 |
| A Study to Find Out How Nintedanib is Taken up in the Body and How Well it is Tolerated in Children and Adolescents With Interstitial Lung Disease (ILD) (NCT04093024) | Boehringer Ingelheim | 2019-12-03 |
| A Study on Whether Patients Prefer the Spiriva® Respimat® or the Spiriva® Handihaler® for Treating Their Chronic Obstructive Pulmonary Disease (COPD) (NCT03964207) | Boehringer Ingelheim | 2019-11-25 |
| A Study Based on Health Insurance Data About the Treatment of Patients Who Have Been Newly Diagnosed With Chronic Obstructive Pulmonary Disease (COPD) (NCT04097223) | Boehringer Ingelheim | 2019-11-20 |
| Characteristics and Treatment Patterns of Patients With Chronic Obstructive Pulmonary Disease (COPD), Initiating Tio+Olo or Other Maintenance Therapies in the US and the UK: A Retrospective Claims Database Study (NCT04926233) | Boehringer Ingelheim | 2019-11-15 |
| A Study in Healthy Men and Women to Test How Well Different Doses of BI 1323495 Are Tolerated (NCT04107805) | Boehringer Ingelheim | 2019-11-04 |
| A Study to Test Different Doses of BI 1701963 Alone and Combined With Trametinib in Patients With Different Types of Advanced Cancer (Solid Tumours With KRAS Mutation) (NCT04111458) | Boehringer Ingelheim | 2019-11-04 |
| Comparative Effectiveness and Safety of Tiotropium and Olodaterol in Comparison to LABA/ICS (NCT04138758) | Boehringer Ingelheim | 2019-11-01 |
| Comparative Effectiveness and Safety of Tiotropium and Olodaterol in Comparison to Triple Therapy (NCT04184297) | Boehringer Ingelheim | 2019-11-01 |
| A Study to Test How Well Healthy Men Tolerate Different Doses of BI 764198 (NCT04102462) | Boehringer Ingelheim | 2019-10-29 |
| Re-usable Respimat® Soft MistTM Inhaler Study (NCT04011735) | Boehringer Ingelheim | 2019-09-30 |
| TARA Working Prototype Engagement Evaluation: Feasibility Study (NCT04085302) | Boehringer Ingelheim | 2019-09-26 |